This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loubinoux, J.
Right arrow Articles by Bouvet, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loubinoux, J.
Right arrow Articles by Bouvet, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2003, p. 1337-1338, Vol. 41, No. 3
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.3.1337-1338.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

CASE REPORT

Bacteremia Caused by Acinetobacter ursingii

Julien Loubinoux,1* Liliana Mihaila-Amrouche,1 Anne Le Fleche,2 Etienne Pigne,3 Gerard Huchon,3 Patrick A. D. Grimont,2 and Anne Bouvet1

Service de Microbiologie,1 Service de Pneumologie, Hôtel Dieu Assistance Publique-Hôpitaux de Paris, Université Paris VI, 75181 Paris Cedex 04,3 Centre d'Identification Moléculaire des Bactéries, Unité de Biodiversité des Bactéries Pathogenes Emergentes, U 389 INSERM, Institut Pasteur, 75724 Paris Cedex 15, France2

Received 12 August 2002/ Returned for modification 10 October 2002/ Accepted 15 December 2002

Acinetobacter ursingii has not been reported in infectious processes apart from its recent description as a new species. A bacteremia caused by A. ursingii in a patient with a pulmonary adenocarcinoma confirms that this microorganism is an opportunistic human pathogen. The isolate was susceptible to imipenem, aminoglycosides, rifampin, and fluoroquinolones.

* Corresponding author. Mailing address: Service de Microbiologie, Hôtel Dieu, 1 place du Parvis Notre-Dame, 75181 Paris Cedex 04, France. Phone: (33) 1 42 34 82 73. Fax: (33) 1 42 34 87 19. E-mail: j.loubinoux{at}voila.fr.

Journal of Clinical Microbiology, March 2003, p. 1337-1338, Vol. 41, No. 3
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.3.1337-1338.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • de la Tabla Ducasse, V. O., Gonzalez, C. M., Saez-Nieto, J. A., Gutierrez, F. (2008). First case of post-endoscopic retrograde cholangiopancreatography bacteraemia caused by Acinetobacter ursingii in a patient with choledocholithiasis and cholangitis. J Med Microbiol 57: 1170-1171 [Abstract] [Full Text]  
  • Kilic, A., Li, H., Mellmann, A., Basustaoglu, A. C., Kul, M., Senses, Z., Aydogan, H., Stratton, C. W., Harmsen, D., Tang, Y.-W. (2008). Acinetobacter septicus sp. nov. Association with a Nosocomial Outbreak of Bacteremia in a Neonatal Intensive Care Unit. J. Clin. Microbiol. 46: 902-908 [Abstract] [Full Text]  
  • Dortet, L., Legrand, P., Soussy, C.-J., Cattoir, V. (2006). Bacterial Identification, Clinical Significance, and Antimicrobial Susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, Two Frequently Misidentified Opportunistic Pathogens. J. Clin. Microbiol. 44: 4471-4478 [Abstract] [Full Text]  
  • Rodriguez-Bano, J., Marti, S., Ribera, A., Fernandez-Cuenca, F., Dijkshoorn, L., Nemec, A., Pujol, M., Vila, J. (2006). Nosocomial Bacteremia Due to an As Yet Unclassified Acinetobacter Genomic Species 17-Like Strain. J. Clin. Microbiol. 44: 1587-1589 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»